Too Fast, Too Furious: Is U.S. Vaccine Development Headed in the Wrong Direction?
As the novel coronavirus pandemic continues to rage across the U.S., people are yearning for a win after Washington’s spectacular failures to secure adequate supplies of testing kits and personal protective equipment. Success hinges on whether any of the fast-tracked Covid-19 vaccine candidates supported by the almost $10 billion federally funded Operation Warp Speed will save the day. With the aim of getting 300 million doses of safe and effective vaccines delivered by January 2021, the challenge is enormous.